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Expression of the cystic fibrosis transmembrane con-
ductance regulator (CFTR) is stringently controlled by
molecular chaperones participating in formation of the
quality control system. It has been shown that about 75%
of all CFTR protein and close to 100% of the [DPhe508]
CFTR variant are rapidly degraded before leaving the
endoplasmic reticulum (ER). B cell antigen receptor-
associated proteins (BAPs) are ubiquitously expressed in-
tegral membrane proteins that may control association
with the cytoskeleton, vesicular transport, or retrograde
transport from the cis Golgi to the ER. The present study
delivers evidence for cytosolic co-localization of both
BAP31 and CFTR and for the control of expression of
recombinant CFTR in Chinese hamster ovary (CHO) cells
and Xenopus oocytes by BAP31. Antisense inhibition of
BAP31 in various cell types increased expression of both
wild-type CFTR and [DPhe508]CFTR and enabled cAMP-
activated Cl2 currents in [DPhe508]CFTR-expressing CHO
cells. Coexpression of CFTR together with BAP31 attenu-
ated cAMP-activated Cl2 currents in Xenopus oocytes.
These data therefore suggest association of BAP31 with
CFTR that may control maturation or trafficking of CFTR
and thus expression in the plasma membrane.
Epithelial Cl2 transport is controlled by the cystic fibrosis
transmembrane conductance regulator (CFTR),1 which is a Cl2
channel and a regulator of other ion channels (1). Cl2 transport
and regulation of ion channels is defective in cystic fibrosis
(CF), because of more than 900 different CFTR mutations. The
most common mutation, [DPhe508]CFTR, leads to a defect in
maturation and processing of the CFTR protein and thus does
not allow for expression of sufficient amounts of CFTR in
plasma membranes of epithelial cells and non-epithelial cells
that express recombinant CFTR (2, 3). It has been shown that
because of incomplete folding, [DPhe508]CFTR is not capable of
leaving the ER and thus is not processed to a more mature and
glycosylated form. Therefore, it does not become protease-re-
sistant, is retained in the ER, and will not undergo complex
glycosylation (4). It is therefore detected as a band of lower
molecular weight when analyzed on an SDS gel (5, 6). Several
proteolytic systems, including proteasomes, contribute to deg-
radation of wild-type CFTR (wtCFTR) and [DPhe508]CFTR (3,
7). The enzymes and compartments responsible for degradation
of CFTR are part of the ER quality control system of secretory
proteins (8). Binding of CFTR to the ER membrane chaperone
calnexin (9) and the cytosolic chaperone Hsp70 or Hsp90 (10,
11) has been demonstrated. Small amounts of [DPhe508]CFTR
that escape proteolysis is trafficked to the cell membrane,
where it functions as cAMP-regulated Cl2 channel (12, 13). This
is usually 1% or less of the amount of wtCFTR present in the
native tissue and is probably higher in Xenopus oocytes (2, 14).
Recently, several proteins have been identified which bind to
B cell antigen receptors (BCR) (15). These BCR-associated pro-
teins (BAPs) were identified initially in mouse B cells and have
been shown to be expressed ubiquitously in various types of
cells, including CHO cells (16). BAP31 and other members of
this family of proteins are present in the ER where they exist as
integral membrane proteins associated with membrane immu-
noglobulin D in B cells (15, 16). It has been suggested that
BAP31 and related proteins play a role in vesicular transport
and control anterograde transport of certain membrane pro-
teins such as cellubrevin (16, 17). We therefore examined in the
present study whether BAP31 also affects expression of CFTR.
We were particularly interested to see whether expression of
[DPhe508]CFTR can be influenced by manipulation of the ex-
pression of BAP31. The data presented here demonstrate that
BAP31 inhibits both expression of wtCFTR as well as
[DPhe508]CFTR and suggest that BAP31 is participating in
formation of the quality control system.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection with BAP31 Antisense Oligonucleo-
tides—CHO cells expressing either wtCFTR or [DPhe508]CFTR (kindly
provided by Dr. X.-B. Chang and Prof. J. Riordan, Mayo Clinic Scotts-
dale, Scottsdale, AZ) were cultured in a-minimum essential medium
supplemented with 8% fetal bovine serum, 50 mmol/liter methotrexate,
penicillin (100 units/ml) and streptomycin (100 mg/ml) (Life Technolo-
gies, Germany) in a humidified atmosphere with 5% CO2 (18). Human
bronchial epithelial cells (16HBE14o2) and mouse epithelial-collecting
duct cells (M1) were cultured as described previously (19, 20). About 5 3
106 CHO cells expressing [DPhe508]CFTR were electroporated in the
presence of 12 nmol/liter (40 mg/ml) of a plasmid encoding the enhanced
green fluorescent protein (pEGFP-c1; CLONTECH, Germany) and
about 0.5 mmol/liter (3.5 mg/ml) phosphorothioated (stabilized) oligonu-
cleotides antisense to the first 20 bases of the BAP31 coding sequence.
Control cells were transfected with EGFP and missense oligonucleo-
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tides only. Cells were electroporated (Bio-Rad) at 400 V/500 mF and
subsequently kept on ice for 10 min. Following, cells were resuspended
in culture medium and plated on culture dishes. Alternatively, cells
were transfected using 1 mmol/liter antisense DNA and the transfection
reagent DOTAP (Roche Molecular Biochemicals) according to the man-
ufacturer’s protocol.
Western Blotting of CFTR and BAP31—Cells were lysed in sample
buffer containing 10% SDS and 100 mmol/liter dithiothreitol. Protein
concentration was determined according to a modified Laury method,
and the lysates containing 20 mg of protein were subjected to SDS-
polyacrylamide gel electrophoresis and analyzed by Western blotting as
described previously (21). Proteins were separated by 7% (CFTR) and
12% (BAP31) SDS-polyacrylamide gel electrophoresis, transferred to
nitrocellulose membranes (Bio-Rad), and bound antibodies were de-
tected by enhanced chemiluminescence (Amersham Pharmacia Bio-
tech) (22). Using the different protocols, antisense transfection and
Western blot analysis were performed three to seven times for each cell
line. A mouse monoclonal antibody (M3A7) was used for detection of
CFTR (kindly provided by Prof. Dr. J. Riordan, Mayo Clinic Scottsdale)
(23). Specific rabbit anti-BAP31 serum has been raised against the GST
fusion protein carrying the C-terminal half of BAP31 (16). Horseradish
peroxidase-conjugated goat anti-mouse antibodies were obtained from
Southern Biotechnology Associates. The goat anti-mouse IgG (H1L)-
DTAF and goat anti-rabbit IgG (H1L)-Texas Red secondary antibody
conjugates were from Jackson Laboratories.
36Cl2 Efflux—CHO cells grown on 35-mm culture dishes were ana-
lyzed for forskolin (10 mmol/liter) activated 36Cl2 efflux. Electroporated
CHO cells were seeded on 35-mm culture dishes and were allowed to
grow to subconfluence for 72 h. After rinsing the culture dishes with
efflux buffer (all mmol/liter) 140 NaCl, 3.3 KH2PO4, 0.83 K2HPO4, 1
CaSO4, 1 MgSO4, 5 HEPES, 10 glucose, pH 7.4, 37 °C) fresh efflux
buffer (1 ml) containing 2 mCi/ml 36Cl2 was added to each dish. Cultures
were incubated for 2 h at 37 °C and then washed three times for 10 s
with efflux buffer. 1 ml of efflux buffer was applied, removed in 1-min
intervals, and replaced by fresh buffer. At 3 min, forskolin (10 mmol/liter)
was added to the buffer. Cells were extracted overnight at 4 °C, remaining
36Cl2 was determined, and samples were counted in scintillation mixture.
The percent efflux/min was calculated according to Ref. 24.
Patch Clamp Analysis and GFP Fluorescence—Cell culture dishes
were mounted on the stage of an inverted microscope (IM35, Zeiss,
Oberkochen, Germany) and kept at 37 °C. The bath was continuously
perfused with Ringer solution at a rate of about 20 ml/min. EGFP
fluorescence was observed at 480-nm excitation and 520-nm emission
using fluorescence microscopy (Zeiss, Oberkochen, Germany). Only
cells demonstrating EGFP fluorescence were used for patch clamp
analysis. During the experiments, 115 mmol/liter Cl2 was replaced by
equimolar concentrations of the impermeable anion gluconate (30Cl2).
Patch clamp analysis was performed in the fast whole cell configuration
according to (25). The patch pipettes had an input resistance of 2–4
megohms and were filled with a solution containing (mmol/liter) KCl
30, potassium gluconate 95, NaH2PO4 1.2, Na2HPO4 4.8, EGTA 1,
CaCl2 0.726, MgCl2 1.034, D-glucose 5, ATP 1. The pH was adjusted to
7.2, the Ca21 activity of this solution was 0.1 mmol/liter. The access
conductance was measured continuously and was between 30 and 120
nanosiemens. Currents (voltage clamp) and voltages (current clamp)
were recorded using a patch clamp amplifier (List Medical Electronic,
Darmstadt, Germany) and were displayed continuously on a pen re-
corder (Gould Instruments). In regular intervals, membrane voltages
(Vc) were clamped in steps of 10 mV to 6 40 mV. Gm was calculated
according to Ohm’s law from the measured I and Vc values (25). CFTR
Cl2 currents were activated by 3-isobutyl-1-methylxanthine (IBMX;
100 mM) and forskolin (10 mM) (Sigma).
Immunofluorescence—CHO cells were grown on coverslips, washed
with ice-cold phosphate-buffered saline containing 0.01% azide and
were fixed with 2% paraformaldehyde in phosphate-buffered saline for
15 min at room temperature and washed three times in phosphate-
buffered saline. Cell were permeabilized with blocking buffer contain-
ing 1% fetal calf serum, 0.01% azide and 0.03% saponin (Sigma-Aldrich)
for 15 min. Cells were incubated with antibodies diluted in blocking
buffer for 15 min at room temperature. Unbound antibodies were re-
moved by washing with blocking buffer. After incubation with second-
ary antibodies, cells were washed three times in blocking buffer, air
dried, and mounted in 10 ml of Fluoromount-G (Southern Biotechnology
Inc.) on a microscope slide. Fluorescence microscopy was conducted
using a LEIKA TCS confocal laser scanning microscope (Leitz,
Germany).
cDNA and in Vitro Transcription of cRNA—To generate the cDNA
encoding BAP31 missing the C-terminal KKXX motif (BAP31-KKXX),
the BAP31-containing plasmid was digested with SmaI/BsaAI and re-
ligated. The resulting cDNA was missing the last 26 nucleotides encod-
ing the C-terminal 8 amino acids. cDNA sequences encoding wtCFTR,
[DF508]CFTR, BAP31, BAP31-KKXX, BAP29, and E3/19k were sub-
cloned into pBluescript SK1 (Stratagene). For in vitro transcription
using either T7 or T3 promoters, plasmids were linearized with KpnI,
BamHI, SalI, and NotI, respectively. In vitro transcription was per-
formed using T7 and T3 polymerase, respectively, and a cap analog
(mCAP RNA capping kit, Stratagene).
Double Electrode Voltage Clamp in Oocytes from Xenopus laevis—
Oocytes were obtained from adult X. laevis frogs, defolliculated by 1-h
treatment with collagenase (type A, Roche Molecular Biochemicals) and
subsequently injected with 10–30 ng of RNA encoding the individual
proteins. Recordings were taken 2–3 days after injection. During two
electrode voltage clamp recordings, i/v curves were obtained every 20 s
by voltage clamping the oocyte from 280 to 140 mV in steps of 20 mV.
Conductances were calculated according to Ohm’s law. Oocytes were
continuously perfused with amphibian Ringer containing 96 mM NaCl,
2 mM KCl, 1.8 mM Ca21, 5 mM HEPES, 1 mM Mg21 at pH 7.55. CFTR
Cl2 currents were activated by IBMX (1 mM) and forskolin (10 mM).
Materials and Statistical Analysis—All used compounds were of
highest available grade of purity. Dimethyl sulfoxide (Me2SO) was from
Merck (Darmstadt, Germany). IBMX and forskolin were from Sigma.
The data are shown as original recordings or as mean values 6 S.E.; n
refers to the number of experiments. Statistical analysis was performed
according to paired or unpaired Student’s t test. p , 0.05 were accepted
to indicate statistical significance (*).
RESULTS
BAP31 Controls Expression of CFTR and Is Colocalized with
CFTR in CHO Cells—[DPhe508]CFTR does not mature properly
and is therefore excluded from the glycosylation pathway.
Thus, [DPhe508]CFTR appears as a lower molecular weight
band on an SDS gel when compared with wtCFTR. We ana-
lyzed expression of wtCFTR and [DPhe508]CFTR in CHO cells
lines stably transfected with either wtCFTR or [DPhe508]CFTR
(4). Mature and fully glycosylated CFTR of molecular weight of
about 180 kDa is detected in wtCFTR-expressing cells whereas
[DPhe508]CFTR appears as a immature precursor of a lower
molecular weight of about 150 kDa (Fig. 1A). CHO cells do also
show expression of BAP31 as indicated by Western blot anal-
ysis (Fig. 1A). Both wtCFTR- and [DPhe508]CFTR-expressing
cells were transfected with BAP31 antisense oligonucleotides
(1 AS), which largely reduced expression of BAP31 when com-
pared with control cells (2AS). Parallel to the reduced expres-
sion of BAP31, we detected an increase in both expression of
wtCFTR as well as [DPhe508]CFTR, suggesting that expression
of CFTR is controlled by BAP31. Experiments were carried out
at least in triplicates but generally 5–7 times. Expression of
BAP31 was also detected in various cultured cell types from
pancreas (CFPAC), collecting duct (M1), colon (HT29 and T84)
and airways (CFDE, 16HBE14o2, 9HTE), although levels of
BAP31 expression varied significantly between the different
cell lines. In all theses cell lines, CFTR is expressed endog-
enously (data not shown). In mouse collecting duct cells (M1)
and human bronchial epithelial cell lines (16HBE14o2; HBE),
expression of BAP31 was blocked by antisense treatment. Re-
duced expression of BAP31 was paralleled by enhanced expres-
sion of CFTR (Fig. 1B). These data suggest that BAP31 also
controls expression of endogenous CFTR in airways and col-
lecting duct of the kidney.
Because Western blot analysis suggested that BAP31 is in-
volved in the control of synthesis and maturation of CFTR, we
performed immunofluorescence stain of both CFTR and BAP31
(Fig. 2). The cells showed a pronounced staining for BAP31
(Texas red fluorescence) and were also significantly stained for
wtCFTR (DTAF green fluorescence). The overlay (yellow fluo-
rescence) of both pictures shows co-staining of the two proteins
except for areas close to the plasma membrane (Fig. 2). These
data suggest that both CFTR and BAP31 are colocalized in the
ER of CHO cells and thus support the idea of BAP31 controlling
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maturation or trafficking of CFTR.
Inhibition of BAP31 Expression Enhances Cl2 Conductance
and Recovers Cl2 Channel Activity in Cells Expressing
[DPhe508]CFTR—To examine whether BAP31 also affects func-
tional expression of CFTR, we analyzed cells transfected with
BAP31 antisense as well as control cells in a 36Cl2 efflux assay.
To that end, electroporated CHO cells were grown on 35 mm-
culture dishes and loaded with 36Cl2. Subsequently, 36Cl2 ef-
flux was measured in the absence or presence of forskolin (10
mmol/liter). As shown in Fig. 3, 36Cl2 efflux was continuously
declining in the absence of forskolin (dashed lines). In wtCFTR-
expressing CHO cells, stimulation with forskolin largely en-
hanced 36Cl2 efflux, indicating activation of a CFTR Cl2 con-
ductance, whereas no 36Cl2 efflux was activated in
[DPhe508]CFTR-expressing CHO cells. However, in BAP31 an-
tisense-treated cells expressing [DPhe508]CFTR, forskolin was
able to induce a small but significant 36Cl2 efflux, and 36Cl2
efflux in wtCFTR-expressing cells was augmented (solid lines,
filled circles). These data suggest that blocking of BAP31 ex-
pression enhances CFTR expression and leads to a residual Cl2
channel activity in [DPhe508]CFTR-expressing CHO cells.
We further cotransfected wtCFTR or [DPhe508]CFTR-ex-
pressing CHO cells with a 40-fold molar excess of BAP31 an-
tisense oligonucleotides and the expression plasmid for green
fluorescent protein (pEGFP-C1). Control cells were transfected
with pEGFP-c1 only. EGFP fluorescence was monitored during
subsequent patch clamp experiments and was used as an indi-
cator for successful transfection. Only fluorescent-labeled cells
were used for patch clamp experiments. Activation of wtCFTR
was studied initially in wtCFTR-expressing cells. Upon stimu-
lation with IBMX (100 mmol/liter) and forskolin (10 mmol/liter),
a large whole cell conductance was activated and the cell mem-
brane voltage (Vm) was depolarized (Fig. 4, A and B, upper
traces). Partial replacement of extracellular Cl2 by imperme-
able gluconate (30Cl2) partially blocked the activated whole
cell conductance and further depolarized Vm, indicating activa-
tion of a whole cell Cl2 conductance. In the absence of BAP31
antisense, [DPhe508]CFTR-expressing cells did not show a re-
sponse to any of the above maneuvers (Fig. 4, A and B, middle
trace). However, in BAP31 antisense-incubated cells, forskolin
and IBMX were able to activate a residual Cl2 conductance as
indicated by changes in whole cell conductance and Vm (Fig. 4,
A and B, lower trace). Fig. 5 summarizes the effects of IBMX
and forskolin and 30Cl2 on whole cell conductances and mem-
brane voltages and clearly indicates a significant cAMP-acti-
vated whole cell Cl2 conductance in CHO cells expressing
[DF508]CFTR after blocking expression of BAP31.
Coexpression of BAP31 and CFTR in Xenopus Oocytes—We
further examined how coexpression of BAP31 affects activation
of wtCFTR in oocytes of X. laevis. Fig. 6A shows whole cell
recordings obtained from oocytes expressing only wtCFTR or
coexpressing wtCFTR together with BAP31. The corresponding
I/V curves are shown in Fig. 6B. The tracings, I/V curves, and
the summary (Fig. 6C) of this series of experiments clearly
show that coexpression of BAP31 attenuates significantly the
activation of a CFTR Cl2 conductance in Xenopus oocytes.
Injection of a non-translated missense-cRNA did not affect
CFTR currents, suggesting that decrease in CFTR is caused by
expression of BAP31 rather than nonspecific effects because of
additional cRNA injection (data not shown).
To further elucidate the impact of BAP expression on CFTR
Cl2 conductance, we coexpressed a BAP31 variant lacking the
last C-terminal 24 nucleotides. This truncated BAP31 version
lacks the C-terminal KKEE amino acid motif, which is known
as an ER retrieval sequence (consensus sequence KKXX) and
which may also have a function as a transport or internaliza-
tion signal (26, 27). The ability to inhibit CFTR expression in
Xenopus oocytes seems to rely on the presence of the KKXX
motif, because BAP31-KKXX was unable to decrease cAMP-
activated CFTR Cl2 conductance (Fig. 7). Transfection with
BAP31 carrying the KKXX may cause an ER overload and may
thus cause stress to the cells (28). To exclude artificial effects
on CFTR Cl2 conductance caused by possible ER stress, we
coexpressed CFTR together with the adenovirus protein E3/
19K. E3/19K has been demonstrated to accumulate in ER
membranes and to cause cells stress, thereby activating the
transcription factor NFkB (28). However, ER stress does not
seem the cause for reduced CFTR expression in Xenopus oo-
cytes, because E3/19K exerted no inhibitory effects on CFTR
Cl2 conductance (Fig. 7). Finally, BAP29, a protein homologous
to BAP31 was coexpressed together with CFTR and slightly but
not significantly attenuated activation of CFTR upon increase
in intracellular cAMP. When coexpressed together with
BAP31, heterodimerization of BAP29 and BAP31 is likely to
occur (16). The putative BAP31/BAP29 heterodimer was also
able to inhibit expression of CFTR Cl2 conductance, as shown
in Fig. 7. Taken together, these data strongly suggest regula-
tion of CFTR expression by BAP31, which might be part of the
quality control system.
FIG. 1. Western blot analysis of the expression of wtCFTR,
[DF508]CFTR and BAP31 in CHO, M1, and HBE cells. Equal
amounts of protein (20 mg) were isolated from CHO cells, grown in the
presence of a BAP31 antisense oligonucleotide (1AS) or missense oli-
gonucleotide (2AS), and from M1 and HBE cells growing in either the
presence or absence of BAP31-antisense, and were separated on SDS
gels. When grown in the presence of antisense nucleotides, expression
of BAP31 was largely reduced in CHO cells (A) and the epithelial cell
lines M1 and HBE (B). The decrease in BAP31 expression was paral-
leled by an increase in CFTR expression in CHO cells, expressing CFTR
exogenously (A), and the epithelial cell lines M1 and HBE, expressing
CFTR endogenously (B). Individual experiments were carried out 3–7
times.
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DISCUSSION
The present data suggest that the putative integral mem-
brane protein BAP31 interferes with expression of CFTR in
heterologous expression systems. BAP31 was identified ini-
tially in the murine myeloma cell line J558L and was shown
later to be expressed in various cell types (15). In the present
study, we detected expression of BAP31 in CHO cells and also
in various types of human epithelial cells lines derived from
colon, pancreas, kidney collecting duct, and airways (data not
shown). Both BAP29 and BAP31 contain three stretches of
hydrophobic amino acids, suggesting that these proteins are
multiple spanning transmembrane proteins (16). When BAP31
expression was blocked by antisense oligonucleotides in CHO
cells, expression of both wtCFTR or [DPhe508]CFTR seemed to
be enhanced. The amount of mature wtCFTR protein was en-
hanced when expression of BAP31 was inhibited in CHO cells,
expressing exogenous wtCFTR. Our data show that this effect
is not limited to cells overexpressing CFTR. In airway epithe-
lial and collecting duct cells, inhibition of BAP31 expression
induced enhanced expression of endogenous CFTR. Expression
of mature [DPhe508]CFTR in CHO cells after BAP31-antisense
FIG. 2. Co-localization of BAP31 and CFTR in CHO cells. Immunofluorescence analysis of CFTR and BAB31 in CHO cells expressing
wtCFTR. CFTR and BAP31 were labeled using respective primary antibodies and goat anti-mouse IgG (H1L)-DTAF (CFTR, green fluorescence)
and goat anti-rabbit IgG (H1L)-Texas Red (BAP31, red fluorescence) secondary antibody conjugates. The overlay (yellow fluorescence) of both
pictures shows co-staining of the two proteins except areas around the plasma membrane.
FIG. 3. Cl2 ion transport measured by 36Cl2 efflux in CHO cells
expressing wtCFTR or [DF508]CFTR. Cells were grown in the pres-
ence of BAP31 antisense oligonucleotides (1BAP31-AS) or missense
oligonucleotides (2BAP31-AS). Forskolin (10 mmol/liter) was added
after 3 min, and efflux was determined for another 2 min (solid line).
Dashed lines indicate time course of non-stimulated cells. Asterisk
indicates significant differences between 2BAP31-AS- and 1BAP31-
AS-treated cells (unpaired Student’s t test).
FIG. 4. Patch clamp analysis of CHO cells expressing wtCFTR
or [DF508]CFTR grown in the presence of BAP31 antisense oli-
gonucleotide (1BAP31-AS) or missense oligonucleotide
(2BAP31-AS). Recordings of the whole cell membrane conductance (A)
and membrane voltage (B). Effects of stimulation with forskolin/IBMX
(10 mmol/liter and 100 mmol/liter) and partial replacement of extracel-
lular Cl2 by gluconate (30Cl2).
FIG. 5. Summary of the patch clamp experiments shown in Fig.
4. A, whole cell currents were activated by IBMX and forskolin in CHO
cells expressing wtCFTR and CHO cells expressing [DPhe508]CFTR
when grown in the presence of BAP31 antisense oligonucleotides. B,
impact of partial replacement of extracellular Cl2 by gluconate (30Cl2)
on whole cell Cl2 conductance activated by forskolin/IBMX. The whole
cell conductance is inhibited by 30Cl2 in CHO cells expressing wtCFTR
and CHO cells expressing [DPhe508]CFTR when grown in the presence
of BAP31 antisense oligonucleotides. C, depolarization of the membrane
voltage (Vm) by 30Cl
2 before and after stimulation with IBMX/forskolin.
Vm is depolarized by 30Cl
2 after stimulation with forskolin/IBMX of CHO
cells expressing wtCFTR and CHO cells expressing [DPhe508]CFTR when
grown in the presence of BAP31 antisense oligonucleotides. (), number of
experiments; *, significant difference from control (paired Student’s
t test).
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treatment was not detected by Western blotting. However, the
immature form of the protein was more abundant in cells
treated with BAP31-antisense. Moreover, functional assays
clearly suggest expression of [DPhe508]CFTR protein in the
plasma membranes of antisense-treated cells. Thus, mutant
CFTR protein may be located in plasma membranes in either
an immature unglycosylated form or the small amounts of
mature [DPhe508]CFTR protein cannot be detected by standard
Western blotting. Even longer exposures of the x-ray films did
not show a CFTR protein band of high molecular weight. How-
ever, it is well known from previous studies that only small
amounts of CFTR are required for functional expression in
epithelial cells (12, 29).
The experiments performed in Xenopus oocytes supply fur-
ther evidence for the impact of BAP31 on processing and ex-
pression of CFTR. Interestingly, coexpression of both BAP29
and BAP31 was even more efficient in inhibiting CFTR expres-
sion, compared with the effects of solely expression of BAP31.
Thus, CFTR may interact with BAP31 homodimers or het-
erodimers of BAP31 and BAP29, which have been reported
previously (16). The present data further stress the importance
of the KKXX motif at the C-terminal end of BAP31, because no
inhibition of CFTR conductance was observed in the absence of
this motif. The KKXX motif is an ER retention signal for
residual proteins of the ER, which cycle between ER and the
Golgi (16, 17). It has also been demonstrated to function as a
transport signal (30). KKXX-carrying proteins bind to COP
proteins and are involved in the retrograde transport from the
cis Golgi to the ER (31, 32). In addition, the KKXX motif may
also serve as an internalization and endocytosis signal (27).
The KKXX motif seems to be crucial for the inhibitory effects of
BAP31 on CFTR. As mentioned above, the KKXX represents an
ER retrieval signal and thus ER overload by overexpressing
BAP31 may lead to cell stress, activation of NFkB, and even-
tually cell death by apoptosis (28, 33). In fact, BAP31 probably
takes part in the control of programmed cell death (34, 35).
Although we cannot completely rule out a possible nonspecific
effect of BAP31 on CFTR expression, we were able to show that
expression of the protein E3/19k that binds very tightly to the
ER and induces ER overload (28) does not interfere with ex-
pression of CFTR in Xenopus oocytes.
Interestingly, it has been shown recently that virus matura-
tion in the ER is controlled by an KKXX ER retrieval signal and
that viruses lacking the envelope glycoprotein encoding the
KKXX motif have a higher chance for budding at the plasma
membrane (36). The present results suggest that trafficking or
maturation of a variety of transmembrane proteins might be
controlled by BAP31, including CFTR. However, it is unlikely
that BAP31 affects expression of all membrane proteins, be-
cause we did not detect an increased expression for the a-sub-
unit of the Na1/K1-ATPase in BAP31-AS treated HBE or M1
cells (data not shown). One function of BAP31 could be that it
participates in formation of the quality control mechanism of
membrane protein synthesis, which was postulated for CFTR
(37). It is now well known that biosynthesis of CFTR is strictly
controlled by this mechanism, resulting in degradation of most
of the wtCFTR and basically all of [DPhe508]CFTR (3). Because
[DPhe508]CFTR is by far the most frequent mutation causing
cystic fibrosis, interfering with the expression or function of
BAP31 in epithelial cells could be a new way to circumvent the
Cl2 channel defect in cystic fibrosis.
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